Wilmington participating in mRNA flu vaccine trials wwaytv3.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wwaytv3.com Daily Mail and Mail on Sunday newspapers.
A local clinical research company is accepting 330 volunteers to test out a plant-based Covid-19 vaccine. Participants will be paid. (Port City Daily/Pexels, courtesy of Kaboompics)
WILMINGTON A local clinical research company, Trial Management Associates (TMA), in conjunction with Wrighstville Family Practice, will be launching a trial for a new Covid-19 vaccine one that is plant-based, according to TMA president Phil Datillo.
Though Datillo can’t reveal the vaccine’s producer or how its concept derived, per confidentiality agreements, he said the vaccine has passed preclinical testing and a Phase 1 trial. Now, it moves on to being tested on volunteers 18 and older for efficacy and prevention against SARS-CoV-2. Participants will be paid and must agree to five in-office visits upon receiving the vaccine.
By Cece Nunn, posted Apr 12, 2021 Trial Management Associates, a Wilmington clinical research firm, and Bart Williams and Will Jones of Wrightsville Family Practice are conducting a trial of a new COVID-19 vaccine using plant-based technology and plant cells, according to an announcement Monday.
Williams, the physician overseeing the trial, said in the news release, “The health and safety of our community continues to be the basis for our research. Finding safe and effective COVID-19 vaccines and having a community comfort level to actually receive the vaccine will be the main way we navigate out of this global pandemic. Some patients in our community are hesitant to receive the current COVID-19 vaccines approved by the FDA. We worked hard to secure this trial because the plant-based technology offers an alternative, and everyone who participates in the trial will ultimately receive the vaccine.”